Abstract:BACKGROUND AND AIM: Hepatocellular carcinoma (HCC) is a major cause of cancer mortality and is increasing incidence worldwide. The aim of this study was to identify the key genes and microRNAs in HCC and explore their potential mechanisms.METHODS: The gene expression profiles of GSE76427, GSE64041, GSE57957, and the microRNA dataset GSE67882 were downloaded from the Gene Expression Omnibus database. The online tool GEO2R was used to obtain differentially expressed genes (DEGs) and miRNAs (DEMs). The gene ontology and the Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis were performed for DEGs using the Database for Annotation, Visualization, and Integrated Discovery. A protein-protein interaction (PPI) network of the DEGs was constructed by Search Tool for the Retrieval of Interacting Genes and visualized by Cytoscape. Moreover, miRecords was used to predict the target genes of DEMs.RESULTS: In total, 106 DEGs were screened out in HCC, consisting of 89 upregulated genes and 17 downregulated genes, which were mainly enriched in biological processes associated with oxidation-reduction process. Besides, the Kyoto Encyclopedia of Genes and Genomes pathways including chemical carcinogenesis, drug metabolism-cytochrome P450, tryptophan metabolism, and retinol metabolism were involved. A PPI network was constructed consisting of 105 nodes and 66 edges. A significant module including nine hub genes, ASPM, AURKA, CCNB2, CDKN3, MELK, NCAPG, NUSAP1, PRC1, and TOP2A, was detected from the PPI network by Molecular Complex Detection. The enriched functions were mainly associated with the mitotic cell cycle process, cell division, and mitotic cell cycle. In addition, a total of 21 DEMs were identified, including 9 upregulated and 12 downregulated miRNAs. Interestingly, ZBTB41 was the potential target of seven miRNAs. Finally, the nine hub genes and three miRNA-target genes expression levels were validated by reverse transcription-polymerase chain reaction. The relative expression levels of nine genes (ASPM, AURKA, CDKN3, MELK, NCAPG, PRC1, TOP2A, ZBTB41, and ZNF148) were significantly upregulated in cancer tissues.CONCLUSION: This study identified the key genes and potential molecular mechanisms underlying the development of HCC, which could provide new insight for HCC interventional strategies.

Elevated expression of sepiapterin reductase, regulator of G protein signaling 1, hypothetical protein CXorf58 homolog, and zinc finger and BTB domain–containing protein 21 isoform X2 is associated with progression of hepatocellular carcinoma

Elevated expression of ISY1, APOA-1, SYNE1, MTG1, and MMP10 at HCC initiation: HCC specific protein network involving interactions of key regulators of lipid metabolism, EGFR signaling, MAPK, and splicing pathways

Zinc Finger Protein 296 Promotes Hepatocellular Carcinoma Progression Via Intervening Interaction Between Macrophages and B Cells.

Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease

Identification of Crucial Genes Based on Expression Profiles of Hepatocellular Carcinomas by Bioinformatics Analysis.

Integrated Bioinformatics Analysis Reveals Key Candidate Genes and Pathways Associated with Clinical Outcome in Hepatocellular Carcinoma

Hepatocellular carcinoma-associated protein markers investigated by MALDI-TOF MS.

Nano-LC-MS/MS Based Proteomics of Hepatocellular Carcinoma Cells Compared to Chang Liver Cells and Tanshinone IIA Induction.

Identification Of Cellular Genes And Pathways Important For Tumorigenicity Of Hepatocellular Carcinoma Cell Lines By Proteomic Profiling

Bioinformatics Analysis to Identify the Key Genes Affecting the Progression and Prognosis of Hepatocellular Carcinoma

Targeting Genes and Signaling Pathways of Transcriptional Suppressor ZHX2 in Hepatocellular Carcinoma: a Chromatin Immunoprecipitation-sequencing (Chip-Seq) Investigation

Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis

Molecular cloning and characterization of a novel gene which is highly expressed in hepatocellular carcinoma

Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues

Deciphering the Protein Protein Interaction Network Regulating Hepatocellular Carcinoma Metastasis

Aberrant expression of cell cycle and material metabolism related genes contributes to hepatocellular carcinoma occurrence.

Key Signaling Pathways, Genes and Transcription Factors Associated with Hepatocellular Carcinoma

Therapeutic targets for hepatocellular carcinoma identified using proteomics and Mendelian randomization

Bioinformatics identification of crucial genes and pathways associated with hepatocellular carcinoma

Identification of Hepatocellular Carcinoma-associated Hub Genes and Pathways by Integrated Microarray Analysis

A Coiled-Coil Domain Containing 50 Splice Variant Is Modulated by Serine/Arginine-Rich Splicing Factor 3 and Promotes Hepatocellular Carcinoma in Mice by the Ras Signaling Pathway.